Join Today & Get 4% Cash Back Then 6, 7...Up to 10% Off Reorders!

Online Pharmacy Dictionary

Find drugs by alphabetical list:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z View All

News on Visudyne (verteporfin)

BC's 100 of influence - Vancouver Sun

BC's 100 of influenceVancouver SunUnder her guidance, QLT developed Visudyne, a treatment for age-related macular degeneration, a leading cause of blindness in the elderly. ...and more��

BUYINS.NET: PSEC, UMC, CTRN, EURX, QLTI, GIVN Expected To Be Down Before Next ... - Trading Markets (press release)

BUYINS.NET: PSEC, UMC, CTRN, EURX, QLTI, GIVN Expected To Be Down Before Next ...Trading Markets (press release)It offers Visudyne, a photosensitizer to treat the eye disease, known as wet age related macular degeneration (wet AMD). Visudyne is also used for the ...

QLT Announces Expansion of Phase 1b Study of Oral Synthetic Retinoid Compound - MarketWatch (press release)

QLT Announces Expansion of Phase 1b Study of Oral Synthetic Retinoid CompoundMarketWatch (press release)We are focused on our commercial product Visudyne(R) for the treatment of wet-AMD, developing drugs to be delivered in our proprietary punctal plug delivery ...QLT expanding disease profile of early-stage eye drugBusiness in Vancouverall 14 news articles��

VEGF Blockers Seem Safe for Macular Degeneration - MedPage Today

VEGF Blockers Seem Safe for Macular DegenerationMedPage TodayBefore June 2006, the approved treatments for neovascular age-related macular degeneration were photodynamic therapy with IV verteporfin (Visudyne) and ...and more��

Visudyne (verteporfin)

Last updated on: Jan 24, 2007

Brand Name:	Visudyne
Active Ingredient:	verteporfin
Strength(s):	15mg
Dosage Form(s):	Intravenous injection
Company Name:	QLT Photo Therapeutics, Inc.
Availability:	Prescription only, professional use only
*Date Approved by FDA:	April 12, 2000
*Approval by FDA does not mean that the drug will be immediately marketed and available for consumers at this time. This information is provided by the U.S. Food & Drug Administration. For more information about this drug, click here.

What is Visudyne used for?

Visudyne is used to treat certain forms of age-related macular degeneration. Macular degeneration is a condition resulting in vision loss. Visudyne is a two-step treatment of injected drug plus red laser light.

Who should not be treated with Visudyne?

You should not be given Visudyne if you are allergic to certain pigments called porphyrins or have a medical condition called porphyria (a disorder of the metabolism that can lead to sensitivity to light).

Special Warning(s) with Visudyne:

Patients treated with Visudyne become more sensitive to the effects of sunlight (photosensitivity) and must avoid exposing skin or eyes to direct sunlight or bright indoor light for at least 5 days.

What should I tell my doctor or health care provider?

Certain medications may interact with Visudyne or increase sensitivity to light. Review all medications you are taking with your health care provider, including those that you take without a prescription.

What are some possible side effects of Visudyne? (This is NOT a complete list of side effects reported with Visudyne. Your health care provider can discuss with you a more complete list of side effects.)